SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (114)11/6/1996 7:18:00 PM
From: Brad C. Dunlap   of 1762
 
Hi Bennett, I have a strong conviction that that the upcoming phase III results are going to be positive and be similar to previous clinicals. Starting next Thursday the American Hematology Society will start to send out the abstracts of the companies that are presenting clinical data at Dec. meeting. I hope to receive my copy in a timely manner but was late in sending my application. In spite of the lousy performance in the stock the more one digs for additional info on Idec, the more exciting the story becomes. Now that the stock is trading closer to its yearly low I suspect that there will be some selling pressure with year end tax loss selling. I do know that there was a small rumor that C2B8 was put on hold by the FDA which was absurd and completely unfounded. It does give us an opportunity to accumulate additional shares at very attractive prices.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News